Is platelet-lymphocyte ratio (PLR) a predictor of thrombosis and together with circulating tumor cells capable to determine recurrence-free survival in patients with gastric cancer?

Is platelet-lymphocyte ratio (PLR) a predictor of thrombosis and together with circulating tumor cells capable to determine recurrence-free survival in patients with gastric cancer?

Introduction: Cancer-associated thrombosis (CAT) is a major cause of morbidity and mortality in oncology patients. There are no accurate risk assessment tools to predict venous thromboembolism (VTE). Circulating tumor cells (CTCs), circulating tumor microemboli (CTM), and high platelet-lymphocyte ra...

Full description

Saved in:
Bibliographic Details
Main Authors: Bruno Soriano Pignataro, Emne Ali Abdallah, Celso Abdon Lopes Mello, Vinicius Fernando Calsavara, Kenji Nishinari, Anna Paula Carreta Ruano, Marcello F. Fanelli, Guilherme Yazbek, Ludmilla Thomé Domingos Chinen
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2022-10-01
Series:Brazilian Journal of Oncology
Subjects:
platelet-lymphocyte ratio
circulating tumor cells
circulating tumor microemboli
thrombosis
gastric cancer
Online Access:https://www.brazilianjournalofoncology.com.br/details/212/en-US/is-platelet-lymphocyte-ratio--plr--a-predictor-of-thrombosis-and-together-with-circulating-tumor-cells-capable-to-determine-recurrence-free-survival-i
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items